Chargement en cours...
Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus
BACKGROUND: The mutant prevention concentration (MPC) reflects the antimicrobial susceptibility of the resistant mutant subpopulations present in large bacterial populations. In principle, combining the MPC with pharmacokinetic measurements can guide treatment to restrict the enrichment of resistant...
Enregistré dans:
| Publié dans: | J Antimicrob Chemother |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4291236/ https://ncbi.nlm.nih.gov/pubmed/25324419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dku389 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|